Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro

被引:31
|
作者
Gao, L [1 ]
Chen, XH [1 ]
Zhang, X [1 ]
Liu, Y [1 ]
Kong, PY [1 ]
Peng, XG [1 ]
Liu, L [1 ]
Liu, H [1 ]
Zeng, DF [1 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China
关键词
umbilical cord blood; stromal cells; Dexter cultures; in vitro expansion; CD34(+) cell;
D O I
10.1016/j.bcmd.2005.12.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic transplantation with human umbilical cord blood (hUCB) in adult recipients is mainly limited by a low CD34(+) cell dose. To break the limit, hUCB as a novel source of hUCB-derived stromal cells was incorporated in an attempt to expand CD34(+) cells from hUCB in vitro. Cord blood CD34(+) cells were separated by MACS system. HUCB-derived stromal cells were cultured by the Dexter system and characterized by morphologic, immunophenotypical, and functional analysis. We studied the effects of hUCB-derived stromal cells, cytokines, and hUCB-derived stromal cells combined with cytokines on expansion of hUCB CD34(+) cells. The CD34(+) cells were assessed for the degree of expansion and the number of colony-forming units in semisolid culture. Our research found that hUCB-derived stromal cells were mainly composed of three kinds of cell components, with CD 106, CD29, CD44, CD45, CD50, CD68, CD31, Fn, Lm, and collagen IV positive, but CD34 negative immunophenotype. Functionally, it was discovered by cell cycle and growth curve analyses that the capability of colony and parietal layer formation of hUCB-derived stromal cells was poorer than that of BM stromal cells, and the doubling time of hUCB-derived stromal cells was longer than that of BM stromal cells. It was indicated by ELISA and RT-PCR that hUCB-derived stromal cells express higher level of TPO and less GM-CSF and SCF than BM stromal cell. Adherent layer of hUCB-derived stromal cells alone or combining with cytokines, increased CD34(+) cell expansion. In vitro formation of CFUs by expanded CD34(+) cells was significantly higher than that of unexpanded CD34(+) cells (P < 0.05). When cocultured with hUCB-derived stromal cells in the presence of cytokines, cell growth was significantly enhanced: CD34(+) cells by 8.02 +/- 0.96-fold, CFU-GM by 217.60 +/- 6.72-fold, CFU-E by 1940.80 +/- 52.78-fold, and CFU-Mg by 142.60 +/- 4.39-fold. HUCB-derived stromal cells have significant superiority on the expansion of CFU-Mg (P < 0.05). The results indicate that human umbilical cord blood-derived stromal cells may be a suitable feeder layer for expansion of hematopoietic progenitors from hUCB in vitro. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 50 条
  • [41] Two CD34+ stem cells from umbilical cord blood enrichment methods
    Pafumi, C
    Bosco, P
    Cavallaro, A
    Farina, M
    Leonardi, I
    Pernicone, G
    Bandiera, S
    Russo, A
    Giardina, P
    Chiarenza, M
    Calogero, AE
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (04) : 239 - 245
  • [42] Human Umbilical Cord Blood-Derived Neural Stem Cell Line as a Screening Model for Toxicity
    Patnaik, Rajashree
    Padhy, Rabindra Nath
    NEUROTOXICITY RESEARCH, 2017, 31 (03) : 319 - 326
  • [43] Human Umbilical Cord Blood-Derived Neural Stem Cell Line as a Screening Model for Toxicity
    Rajashree Patnaik
    Rabindra Nath Padhy
    Neurotoxicity Research, 2017, 31 : 319 - 326
  • [44] Effects of human umbilical cord blood CD34+ cell transplantation in neonatal hypoxic-ischemia rat model
    Yu, Yan
    Yan, YiZhong
    Luo, Zhen
    Luo, Pan
    Xiao, Na
    Sun, Xuan
    Cheng, LaMei
    BRAIN & DEVELOPMENT, 2019, 41 (02) : 173 - 181
  • [45] Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells
    Um, Soyoun
    Ha, Jueun
    Choi, Soo Jin
    Oh, Wonil
    Jin, Hye Jin
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (12): : 1511 - 1528
  • [46] Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells
    Damien, Pauline
    Allan, David S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1545 - 1554
  • [47] Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells
    Bougioukli, Sofia
    Saitta, Biagio
    Sugiyama, Osamu
    Tang, Amy H.
    Elphingstone, Joseph
    Evseenko, Denis
    Lieberman, Jay R.
    HUMAN GENE THERAPY, 2019, 30 (07) : 906 - 917
  • [48] Analysis of cytokines in umbilical cord blood-derived multipotent stem cell
    Hwang, Soo Han
    Kim, Mi Ho
    Yang, Il Ho
    Bahk, Jong Yoon
    Han, Hoon
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2007, 12 (01) : 32 - 38
  • [49] Analysis of cytokines in umbilical cord blood-derived multipotent stem cell
    Soo Han Hwang
    Mi Ho Kim
    Il Ho Yang
    Jong Yoon Bahk
    Hoon Han
    Biotechnology and Bioprocess Engineering, 2007, 12 : 32 - 38
  • [50] Transplantation of human umbilical cord blood-derived adherent progenitors into the developing rodent brain
    Coenen, M
    Kögler, G
    Wernet, P
    Brüstle, O
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (08) : 681 - 688